These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64. Characterization of myelodysplastic syndrome and aplastic anemia by immunostaining of p53 and hemoglobin F and karyotype analysis: differential diagnosis between refractory anemia and aplastic anemia. Iwasaki T; Murakami M; Sugisaki C; Sobue S; Ohashi H; Asano H; Suzuki M; Nakamura S; Ito M; Murate T Pathol Int; 2008 Jun; 58(6):353-60. PubMed ID: 18477214 [TBL] [Abstract][Full Text] [Related]
65. Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones. Park SH; Jeong J; Lee SH; Yoo DW; Choi Y; Jo JC; Lim JH Ann Lab Med; 2019 Mar; 39(2):150-157. PubMed ID: 30430777 [TBL] [Abstract][Full Text] [Related]
66. Next-Generation Gene Sequencing Differentiates Hypoplastic Myelodysplastic Syndrome from Aplastic Anemia. Lew JL; Fenderson JL; Carmichael MG Hawaii J Med Public Health; 2017 Nov; 76(11 Suppl 2):10-12. PubMed ID: 29164009 [TBL] [Abstract][Full Text] [Related]
72. Early Detection of Myelodysplastic Syndrome/Leukemia-associated Mutations Using NGS Is Critical in Treating Aplastic Anemia. Li X; Wu YH; Cai SS; Li WM; You Y; Zhang M Curr Med Sci; 2019 Apr; 39(2):217-221. PubMed ID: 31016513 [TBL] [Abstract][Full Text] [Related]
73. Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA). Li X; Xu F; He Q; Wu L; Zhang Z; Chang C Intern Med; 2010; 49(14):1349-55. PubMed ID: 20647647 [TBL] [Abstract][Full Text] [Related]
74. [Survey on examinations for diagnosis of bone marrow failure in Japan: a report from the Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes]. Araseki K; Matsuda A; Tohyama K; Ishikawa T; Kawabata H; Miyazaki Y; Nakao S; Tomonaga M; Takaori-Kondo A; Kurokawa M; Omine M; Ozawa K Rinsho Ketsueki; 2012 Jul; 53(7):691-7. PubMed ID: 22975771 [TBL] [Abstract][Full Text] [Related]
75. Late clonal diseases of treated aplastic anemia. Socié G; Rosenfeld S; Frickhofen N; Gluckman E; Tichelli A Semin Hematol; 2000 Jan; 37(1):91-101. PubMed ID: 10676914 [TBL] [Abstract][Full Text] [Related]
76. Aplastic Anemia & MDS International Foundation (AA&MDSIF): bone marrow failure disease scientific symposium 2012. Savage SA; Pulsipher MA; Romano A; Berlyne D Leuk Res; 2013 Jul; 37(7):848-51. PubMed ID: 23643149 [TBL] [Abstract][Full Text] [Related]
77. Clonal evolutions during long-term cultures of bone marrow from de novo acute myeloid leukaemia with trilineage myelodysplasia and with myelodysplastic remission marrow. Tamura S; Kanamaru A; Takemoto Y; Kakishita E; Nagai K Br J Haematol; 1993 Jun; 84(2):219-26. PubMed ID: 8398821 [TBL] [Abstract][Full Text] [Related]
78. Hypoplastic myelodysplastic syndromes can be distinguished from acquired aplastic anemia by CD34 and PCNA immunostaining of bone marrow biopsy specimens. Orazi A; Albitar M; Heerema NA; Haskins S; Neiman RS Am J Clin Pathol; 1997 Mar; 107(3):268-74. PubMed ID: 9052376 [TBL] [Abstract][Full Text] [Related]
79. Cell cycling stress in the monocyte line as a risk factor for progression of the aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome to myelodysplastic syndrome. Nissen C; Genitsch A; Sendelov S; Dalle Carbonare V; Wodnar-Filipowicz A Acta Haematol; 2000; 103(1):33-40. PubMed ID: 10705157 [TBL] [Abstract][Full Text] [Related]
80. [Comparisons of clinical features of chronic aplastic anemia and myelodysplastic syndrome in children]. Hao JJ; Qiu YN; Zhou DF; Xiao Y; Liu Q; Jin RM Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):867-9. PubMed ID: 22099192 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]